News

Hosted on MSN9mon
FDA expands approval of breast cancer drug Kisqali to earlier stage patients - MSN
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said. Story by Mustafa Fattah and Marina Kopf and Kathy Park ...
NBC New York9mon
FDA expands approval of breast cancer drug Kisqali - NBC New York
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The drug was found to reduce the risk of a patient's ...
NBC News9mon
Breast cancer treatment: Drug Kisqali approval expanded for earlier stage disease - NBC News
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said. The drug was found to reduce the risk of a patient's ...
NBC DFW9mon
FDA expands approval of breast cancer drug Kisqali to earlier stage patients - NBC 5 Dallas-Fort Worth
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The drug was found to reduce the risk of a patient's ...
UPI9mon
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment ...
NBC Washington9mon
FDA expands approval of breast cancer drug Kisqali - NBC4 Washington
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The drug was found to reduce the risk of a patient's ...
NBC 6 South Florida9mon
FDA expands approval of breast cancer drug Kisqali - NBC 6 South Florida
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The drug was found to reduce the risk of a patient's ...
U.S. News & World Report9mon
FDA Expands Use of Breast Cancer Drug Kisqali - U.S. News & World Report
“The FDA approval of Kisqali for this early breast cancer population, including those with NO [hasn't spread to nearby lymph nodes] disease, is a pivotal moment in improving our approach to care ...
Hosted on MSN9mon
FDA expands approval of breast cancer drug Kisqali: What to know - MSN
The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of ...
NBC Los Angeles9mon
FDA expands approval of breast cancer drug Kisqali - NBC Los Angeles
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The drug was found to reduce the risk of a patient's ...
Today9mon
FDA expands approval of breast cancer drug Kisqali: What to know
The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of ...
NECN9mon
FDA expands approval of breast cancer drug Kisqali – NECN
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The drug was found to reduce the risk of a patient's ...